Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Sells LIMS Business to LabVantage

NEW YORK (GenomeWeb News) – Life Technologies said today that it will sell its lab information management software business to LabVantage Solutions for an undisclosed sum.

The SQL*LIMS business offers a management system for lab processes, such as tracking raw materials and samples, analyzing samples, collecting data, and communicating this information to corporate systems.

"While the LIMS business is an important asset for a segment of our customers, it was not a perfect fit with our strategic direction," Life Technologies President and COO Mark Stevenson said in a statement. "This agreement will allow us to better focus on our strengths, while ensuring continued access to a key solution in the laboratory workflow."

LabVantage, which is based in Bridgewater, NJ, and specializes in lab information management systems, will continue to support the SQL*LIMS customers.

"We are confident that our customers will benefit from the increased focus of a software solutions company," said Pat Pijanowski, GM of Life Technologies' SQL*LIMS unit. Pijanowski also said that the combination of the businesses "will allow for expanded and strengthened product offerings to meet the needs of this market."

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.